💨 Abstract
A new AI test can identify men with high-risk prostate cancer who would benefit from abiraterone, a drug that extends life by inhibiting testosterone production in tumors. The AI analyzes tumor samples to detect features invisible to the human eye, determining who needs the drug. Trials showed that 25% of high-risk patients could benefit, potentially saving the NHS money. Giles Turner, a patient, highlights the drug's cost and advocates for its free availability in England.
Courtesy: Jasper King
Suggested
Britain to spend £1,500,000,000 on new weapons factories in ‘message’ to Putin
Defence Secretary says UK has ‘lost control of borders’ after 1,200 cross Channel
Why so many young Brits are being ‘manipulated’ into smuggling drugs
British Airways steward detained after ‘drug-fuelled’ dance in business class
London station where ‘fights broke out over lift’ closing this weekend for a year
Peru Two drug mule warns Britons of ‘hellish conditions’ inside prison
Fears grow for British tourist who vanished on first night of stag do in Algarve party hotspot
Urgent recall of 256,000 pounds of canned beef stew over fears they contain wood pieces
British flight attendant ‘in tears’ in court accused of smuggling 46kg of drugs